Sleep Treatments | Sleep Review
For obstructive sleep apnea patients affected by Philips’ recall, ProSomnus Sleep Technologies released a statement stating that there is “a scalable, rapid seven-day production schedule to get patients into therapy faster. The capacity can easily be expanded to cope with this crisis. “
“The aim is to help sleep physicians and dental sleep service providers to enable affected patients to receive safe, comfortable and effective therapy again,” said Len Liptak, CEO of ProSomnus, in a press release. “It is understandable that many affected patients prefer alternatives without CPAP. We want the sleep medicine community to know that ProSomnus is a partner they can trust with oral appliance therapy. “
Sleep doctor Edward T. Sall, MD, DDS, MBA, Medical Director at ProSomnus says in a press release: “Due to the currently limited availability of devices and a complex payment structure for replacing them, ProSomnus OSA Therapy is an exceptional solution. This California medical device manufacturer can scale its artificial intelligent design and robotic manufacturing …. My recently published poster summary of the AASM (American Academy of Sleep Medicine) also demonstrates the effectiveness and effectiveness of these devices in light, moderate and selected heavy patients. “
Mark T. Murphy, DDS, DABDSM, Faculty Director of Clinical Education, said in a press release, “There has never been a better time to use this valuable alternative solution to improve the lives of so many. Treating doctors should commission qualified ProSomnus providers to resolve this crisis quickly.